North East and North Cumbria
ICS Formulary
ICS Formulary
2 Cardiovascular system
02-05-05 Drugs affecting the renin-angiotensin system
| Sparsentan Filspari® |
|
Formulary
|
|
 NICE TA1074: Sparsentan for treating primary IgA nephropathy |
|
Links
- Academic Health Science Network (North East and North Cumbria) - Atrial Fibrilation
- MHRA Drug Safety Update (Feb 2016): Spironolactone and renin-angiotensin system drugs in heart failure: risk of potentially fatal hyperkalaemia.
- MHRA Drug Safety Update (June 2014): Combination use of medicines from different classes of renin-angiotensin system blocking agents: risk of hyperkalaemia, hypotension, and impaired renal function—new warnings
- NICE NG148: Acute kidney injury: prevention, detection and management
- NICE NG191: COVID-19 rapid guideline: managing COVID-19
- NICE TA1074: Sparsentan for treating primary IgA nephropathy